Tapentadol, Oral: References

NUCYNTA ER- tapentadol hydrochloride tablet, film coated, extended release. Janssen Pharmaceuticals, Inc. U.S. National Library of Medicine, National Institutes of Health, DailyMed. Accessed May 10, 2016 from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4c911f3-484b-44fa-833e-2d970d39be8f&audience=consumer

NUCYNTA- tapentadol hydrochloride tablet, film coated. Janssen Pharmaceuticals, Inc. U.S. National Library of Medicine, National Institutes of Health, DailyMed. Accessed May 10, 2016 from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00a8921e-46a6-4df1-a744-9e532b6fb06f&audience=consumer

NUCYNTA- tapentadol hydrochloride solution. Janssen Pharmaceuticals, Inc. U.S. National Library of Medicine, National Institutes of Health, DailyMed. Accessed May 11, 2016 from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e921054f-b3f1-4624-8edd-f6628c6f0fd9&audience=consumer

Janssen Pharmaceuticals, Inc. Completes Divestiture of U.S. License Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) Oral Solution to Depomed, Inc. Accessed May 11, 2016 from http://www.prnewswire.com/news-releases/janssen-pharmaceuticals-inc-completes-divestiture-of-us-license-rights-to-nucynta-tapentadol-nucynta-er-tapentadol-extended-release-tablets-and-nucynta-tapentadol-oral-solution-to-depomed-inc-300060522.html

Opioid Pain Medicine Safety Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications (posted 3/22/2016). FDA. Accessed May 11, 2016 from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm491715.htm and http://www.fda.gov/Drugs/DrugSafety/ucm489676.htm

Tapentadol. Lexi-Comp ONLINE, 2016 Lexi-Comp, Inc. Accessed May 10, 2016 from http://online.lexi.com.

Tapentadol. DRUGDEX® System. 2016 Truven Health Analytics Inc. Accessed May 10, 2016 from http://www.thomsonhc.com